These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17043838)
41. Role of rehabilitation in Hurler's syndrome. Mishra SR; Shastri M; Ramesh J J Back Musculoskelet Rehabil; 2017; 30(3):635-639. PubMed ID: 27911282 [TBL] [Abstract][Full Text] [Related]
42. Outcome of second hematopoietic cell transplantation in Hurler syndrome. Grewal SS; Krivit W; Defor TE; Shapiro EG; Orchard PJ; Abel SL; Lockman LA; Ziegler RS; Dusenbery KE; Peters C Bone Marrow Transplant; 2002 Mar; 29(6):491-6. PubMed ID: 11960268 [TBL] [Abstract][Full Text] [Related]
43. Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children. Soni-Jaiswal A; Mercer J; Jones SA; Bruce IA; Callery P Orphanet J Rare Dis; 2016 Jul; 11(1):96. PubMed ID: 27406185 [TBL] [Abstract][Full Text] [Related]
44. Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase). Tylki-Szymanska A; Rozdzynska A; Jurecka A; Marucha J; Czartoryska B Mol Genet Metab; 2010 Jan; 99(1):10-7. PubMed ID: 19783188 [TBL] [Abstract][Full Text] [Related]
45. A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome. Whitley CB; Gorlin RJ; Krivit W Am J Med Genet; 1987 Sep; 28(1):233-43. PubMed ID: 3118714 [TBL] [Abstract][Full Text] [Related]
46. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. Ghosh A; Miller W; Orchard PJ; Jones SA; Mercer J; Church HJ; Tylee K; Lund T; Bigger BW; Tolar J; Wynn RF Mol Genet Metab; 2016 Mar; 117(3):373-7. PubMed ID: 26832957 [TBL] [Abstract][Full Text] [Related]
47. Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I. Dickson PI; Kaitila I; Harmatz P; Mlikotic A; Chen AH; Victoroff A; Passage MB; Madden J; Le SQ; Naylor DE; Mol Genet Metab; 2015; 116(1-2):69-74. PubMed ID: 26260077 [TBL] [Abstract][Full Text] [Related]
48. [Hurler syndrome: early diagnosis and treatment]. Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225 [TBL] [Abstract][Full Text] [Related]
49. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler. Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599 [TBL] [Abstract][Full Text] [Related]
50. Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I. Kuiper GA; Nijmeijer SCM; Roelofs MJM; van der Lee JH; Hollak CEM; Bosch AM J Inherit Metab Dis; 2019 Sep; 42(5):762-775. PubMed ID: 31020996 [TBL] [Abstract][Full Text] [Related]
52. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104 [TBL] [Abstract][Full Text] [Related]
53. Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report. Soni S; Hente M; Breslin N; Hersh J; Whitley C; Cheerva A; Bertolone S Pediatr Transplant; 2007 Aug; 11(5):563-7. PubMed ID: 17631030 [TBL] [Abstract][Full Text] [Related]
54. [Outcome of two patients with Hurler's syndrome under enzyme replacement therapy with human recombinant alpha-L-iduronidase]. Sardón O; García Pardos C; Mintegui J; Pérez Ruiz E; Coll MJ; Chabás A; Olivé T; Ruiz Benito A An Pediatr (Barc); 2005 Jul; 63(1):61-7. PubMed ID: 15989873 [TBL] [Abstract][Full Text] [Related]
55. Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies. Xue Y; Richards SM; Mahmood A; Cox GF Mol Genet Metab; 2016 Apr; 117(4):419-26. PubMed ID: 26920513 [TBL] [Abstract][Full Text] [Related]
56. Long-term outcome of Hurler syndrome following bone marrow transplantation. Whitley CB; Belani KG; Chang PN; Summers CG; Blazar BR; Tsai MY; Latchaw RE; Ramsay NK; Kersey JH Am J Med Genet; 1993 Apr; 46(2):209-18. PubMed ID: 8484412 [TBL] [Abstract][Full Text] [Related]
57. Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I. Anbu AT; Mercer J; Wraith JE J Inherit Metab Dis; 2006 Feb; 29(1):230-1. PubMed ID: 16601901 [TBL] [Abstract][Full Text] [Related]
58. Enzyme-replacement therapy in mucopolysaccharidosis I. Kakkis ED; Muenzer J; Tiller GE; Waber L; Belmont J; Passage M; Izykowski B; Phillips J; Doroshow R; Walot I; Hoft R; Neufeld EF N Engl J Med; 2001 Jan; 344(3):182-8. PubMed ID: 11172140 [TBL] [Abstract][Full Text] [Related]
59. Combined Hurler and Sanfilippo syndrome in a sibling pair. Sun A; Hopwood JJ; Thompson J; Cederbaum SD Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040 [TBL] [Abstract][Full Text] [Related]
60. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I. Fleming DR; Henslee-Downey PJ; Ciocci G; Romond EH; Marciniak E; Munn RK; Thompson JS Pediatr Transplant; 1998 Nov; 2(4):299-304. PubMed ID: 10084733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]